Claritag

What Claritag does

Claritag, operated under DGI Group LLC (New Jersey, USA), markets an FDA-cleared, at-home skin tag removal device built around patented Squeeze & Freeze cryogenic technology. The device uses liquid cooling gas infused foam treatment pads and a tweezer-head architecture to encapsulate and freeze individual skin tags, with claims that treated tags fall off within 7-14 days. The core product is the Claritag Advanced Skin Tag Removal Device ($24.99 per kit, up to 10 treatments), supported by a Foam Pad Replacement Kit ($9.99) for continued or multi-user use; both ship globally with free shipping and a money-back guarantee.

The company's go-to-market is a hybrid direct-to-consumer and healthcare provider model. Primary revenue is generated through self-serve e-commerce on its Shopify-based website, with top-of-funnel demand built via social channels (Twitter, Facebook, Instagram, YouTube) and a Knowledge Hub content blog. A parallel Healthcare Provider (HCP) program targets dermatologists, general practitioners, pediatricians, and skincare specialists, enabling them to dispense samples and vouchers and to act as Claritag Healthcare Ambassadors who resell the product within their practices.

The business operates as a private LLC with 11-50 employees and is positioned as the #1 FDA-cleared skin tag removal device, supported by 4.9/5 customer ratings across approximately 185 verified reviews. Headcount range, review volume, and absence of disclosed revenue or external funding indicate a small-scale operation, while multilingual site localization (English, Spanish, French) and stated global shipping scope suggest early cross-border DTC ambitions.

Name

Claritag

Legal name

DGI Group LLC

Website

https://claritag.com/

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Claritag, operating under DGI Group LLC, sells an FDA-cleared, patented cryogenic at-home skin tag removal device to consumers globally via direct-to-consumer e-commerce and a healthcare provider ambassador program.

Ownership category

akta.pro rank

Product category

Consumer Health Devices

NAICS

Surface Active Agent Manufacturing (325613)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• At-home skin tag removal
• Cryogenic removal device
• FDA-cleared OTC device
• Skin lesion treatment
• Dermatologist developed skincare

Headquarters

HQ city

Lakewood

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

1. Claritag Device Sales: One-time purchase of the Claritag Advanced Skin Tag Removal Device at $24.99. Each kit includes the device and foam treatment pads sufficient for up to 10 treatments.
2. Foam Pad Replacement Kit Sales: Replacement foam pads sold at $9.99 for continued use of the device, enabling treatment of additional family members or ensuring hygiene.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Claritag sells an FDA-cleared, dermatologist-developed at-home skin tag removal device based on patented Squeeze & Freeze® cryogenic technology. The tweezer-head device uses liquid cooling gas infused foam pads to encapsulate and freeze skin tags, causing them to fall off within 7-14 days. The primary kit ($24.99) treats up to 10 skin tags and is supported by a $9.99 Foam Pad Replacement Kit (16 pads) for additional treatments and hygiene.

Product overview

Claritag offers a two-product portfolio centered on at-home skin tag removal. The primary offering is the Claritag Advanced Skin Tag Removal Device, an FDA-cleared cryogenic device with patented Squeeze & Freeze technology that treats skin tags in 7-14 days with up to 10 treatments per kit. This core device is supported by the Foam Pad Replacement Kit accessory, which provides additional foam pads for treating multiple family members or replacing worn pads for continued use.

Differentiator

Problem solved

Functional benefit

Brands

• Squeeze & Freeze: Patented cryogenic technology used in Claritag skin tag removal device that employs foam treatment pads infused with liquid cooling gas to freeze and remove skin tags.

Products and services

• Claritag Advanced Skin Tag Removal Device

Quantifiable outcome

• Skin tags fall off within 7-14 days, most commonly within 10 days
• +2 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Compound W (Prestige Consumer Healthcare): The leading OTC cryogenic wart and skin lesion removal brand in North America, owned by Prestige Consumer Healthcare. Directly comparable in that it sells FDA-cleared cryogenic freeze applicators for at-home lesion removal, competing with Claritag for the same self-treatment shopper.
• Dr. Scholl's Freeze Away (Church & Dwight): Church & Dwight's OTC cryogenic wart and skin lesion removal product. Closely comparable mechanism (cryogenic freeze applicator) and target use case (at-home removal of benign skin lesions), competing head-to-head with Claritag in the same retail and digital channels.
• Wart-Off: OTC cryogenic and topical wart/skin lesion removal brand. Compares to Claritag as another FDA-cleared consumer dermatology device targeting self-treatment of benign skin lesions, with overlapping product positioning and customer segments.
• TagBand: UK-based direct-to-consumer skin tag removal device using band ligation rather than cryogenics. Closely comparable as a niche DTC brand focused exclusively on at-home skin tag removal, addressing the same pain points (avoiding doctor visits, cost) for the same end consumer.

Broad incumbents

• Prestige Consumer Healthcare: Public OTC consumer healthcare company that owns Compound W, Dr. Scholl's, and many other OTC dermatology and personal care brands. Broad incumbent with deep retail relationships, mass-market advertising, and the portfolio scale that Claritag lacks in dermatology OTC.
• Church & Dwight: Large diversified personal care and household products company behind Dr. Scholl's and numerous OTC brands. Comparable as a broad incumbent with established retail distribution, R&D capability, and regulatory expertise that could easily extend into the at-home skin tag category.
• Bayer Consumer Health: Global OTC healthcare division with dermatology and self-care brands. Comparable as a broad incumbent operating in adjacent OTC dermatology categories with international regulatory infrastructure that could be redeployed into at-home skin tag treatment.
• Galderma: Global dermatology-focused pharmaceutical and consumer company behind brands like Differin and Cetaphil. Comparable as a dermatology specialist incumbent with strong dermatologist relationships that overlap with Claritag's HCP channel strategy.
• Beiersdorf: Global skin care company behind Eucerin, NIVEA, and Hansaplast. Comparable as a broad incumbent in dermatology-adjacent consumer skin care with strong brand equity in pharmacies and the same OTC shelf space Claritag competes for.

Emerging players

• SkinStylus / MicroPen: Emerging DTC dermatology device brand offering at-home microneedling and skin rejuvenation tools. Comparable as an emerging direct-to-consumer beauty-device brand leveraging the same at-home treatment, e-commerce, and influencer-driven channels that Claritag depends on.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xtwitter.com/claritag_dgi
• YouTubeyoutube.com/channel/UCH0Fj1strA5SXaFDSLK9_ww
• Facebookfacebook.com/61550247864342
• Instagraminstagram.com/claritagadvanced
• LinkedInlinkedin.com/company/tuviderm

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Claritag